WINTON GROUP Ltd - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 37 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$519,000
+45.4%
23,607
-11.4%
0.03%
+52.6%
Q2 2021$357,000
+72.5%
26,655
+31.1%
0.02%
+58.3%
Q1 2021$207,000
+200.0%
20,328
+24.1%
0.01%
+140.0%
Q4 2020$69,000
-6.8%
16,375
-42.2%
0.01%
+150.0%
Q3 2020$74,00028,3380.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders